Loss of the Max-interacting protein Mnt in mice results in decreased viability, defective embryonic growth and craniofacial defects: relevance to Miller-Dieker syndrome.


Journal article


K. Toyo-oka, S. Hirotsune, M. Gambello, Zi-Qiang Zhou, Lorin E. Olson, M. Rosenfeld, R. Eisenman, P. Hurlin, A. Wynshaw-Boris
Human molecular genetics, vol. 13(10), 2004, pp. 1057-1067

Semantic Scholar DOI PubMed
Cite

Cite

APA   Click to copy
Toyo-oka, K., Hirotsune, S., Gambello, M., Zhou, Z.-Q., Olson, L. E., Rosenfeld, M., … Wynshaw-Boris, A. (2004). Loss of the Max-interacting protein Mnt in mice results in decreased viability, defective embryonic growth and craniofacial defects: relevance to Miller-Dieker syndrome. Human Molecular Genetics, 13(10), 1057–1067.


Chicago/Turabian   Click to copy
Toyo-oka, K., S. Hirotsune, M. Gambello, Zi-Qiang Zhou, Lorin E. Olson, M. Rosenfeld, R. Eisenman, P. Hurlin, and A. Wynshaw-Boris. “Loss of the Max-Interacting Protein Mnt in Mice Results in Decreased Viability, Defective Embryonic Growth and Craniofacial Defects: Relevance to Miller-Dieker Syndrome.” Human molecular genetics 13, no. 10 (2004): 1057–1067.


MLA   Click to copy
Toyo-oka, K., et al. “Loss of the Max-Interacting Protein Mnt in Mice Results in Decreased Viability, Defective Embryonic Growth and Craniofacial Defects: Relevance to Miller-Dieker Syndrome.” Human Molecular Genetics, vol. 13, no. 10, 2004, pp. 1057–67.


BibTeX   Click to copy

@article{k2004a,
  title = {Loss of the Max-interacting protein Mnt in mice results in decreased viability, defective embryonic growth and craniofacial defects: relevance to Miller-Dieker syndrome.},
  year = {2004},
  issue = {10},
  journal = {Human molecular genetics},
  pages = {1057-1067},
  volume = {13},
  author = {Toyo-oka, K. and Hirotsune, S. and Gambello, M. and Zhou, Zi-Qiang and Olson, Lorin E. and Rosenfeld, M. and Eisenman, R. and Hurlin, P. and Wynshaw-Boris, A.}
}

Abstract

The Mnt gene encodes a Mad-family bHLH transcription factor located on human 17p13.3. Mnt is one of 20 genes deleted in a heterozygous fashion in Miller-Dieker syndrome (MDS), a contiguous gene syndrome that consists of severe neuronal migration defects and craniofacial dysmorphic features. Mnt can inhibit Myc-dependent cell transformation and is hypothesized to counterbalance the effects of c-Myc on growth and proliferation in vivo by competing with Myc for binding to Max and by repressing target genes activated by Myc : Max heterodimers. Unlike the related Mad family members, Mnt is expressed ubiquitously and Mnt/Max heterodimers are found in proliferating cells that contain Myc/Max heterodimers, suggesting a unique role for Mnt during proliferation. To examine the role of Mnt in vivo, we produced mice with null (Mnt(KO)) and loxP-flanked conditional knock-out (Mnt(CKO)) alleles of Mnt. Virtually all Mnt(KO/KO) mutants in a mixed (129S6 x NIH Black Swiss) or inbred (129S6) genetic background died perinatally. Mnt-deficient embryos exhibited small size throughout development and showed reduced levels of c-Myc and N-Myc. In addition, 37% of the mixed background mutants displayed cleft palate as well as retardation of skull development, a phenotype not observed in the inbred mutants. These results demonstrate an important role for Mnt in embryonic development and survival, and suggest that Mnt may play a role in the craniofacial defects displayed by MDS patients.





Follow this website


You need to create an Owlstown account to follow this website.


Sign up

Already an Owlstown member?

Log in